BeOne Medicines (ONC) Net Cash Flow Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 33.37% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -29.82% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 32.17% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 38.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.47% |
| Dec 31, 2025 | 47.67% |
| Sep 30, 2025 | 89.73% |
| Jun 30, 2025 | -3.87% |
| Mar 31, 2025 | -43.94% |
| Dec 31, 2024 | -26.13% |
| Sep 30, 2024 | 29.44% |
| Jun 30, 2024 | -11.34% |
| Mar 31, 2024 | -38.89% |
| Dec 31, 2023 | 38.75% |
| Sep 30, 2023 | -71.78% |
| Jun 30, 2023 | 53.88% |
| Mar 31, 2023 | -31.13% |
| Dec 31, 2022 | -10.52% |
| Sep 30, 2022 | -118.07% |
| Jun 30, 2022 | 17.43% |
| Mar 31, 2022 | -41.99% |
| Dec 31, 2021 | 393.81% |
| Sep 30, 2021 | -53.32% |
| Jun 30, 2021 | -54.01% |
| Mar 31, 2021 | 25.54% |
| Dec 31, 2020 | -74.11% |
| Sep 30, 2020 | 59.02% |
| Jun 30, 2020 | -79.22% |
| Mar 31, 2020 | 406.30% |
| Dec 31, 2019 | -442.43% |
| Sep 30, 2019 | -43.52% |
| Jun 30, 2019 | 45.39% |
| Mar 31, 2019 | -38.93% |
| Dec 31, 2018 | 70.30% |
| Sep 30, 2018 | 348.92% |
| Jun 30, 2018 | 24.66% |
| Mar 31, 2018 | 721.39% |